Boston Scientific Corp. (BSX)
44.20
-0.93
(-2.06%)
USD |
NYSE |
Nov 12, 16:00
44.30
+0.10
(+0.23%)
Pre-Market: 07:42
Boston Scientific Market Cap : 64.07B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 64.07B |
| November 11, 2026 | 65.41B |
| November 10, 2026 | 64.79B |
| November 09, 2026 | 63.81B |
| November 06, 2026 | 61.96B |
| November 05, 2026 | 64.70B |
| November 04, 2026 | 66.41B |
| November 03, 2026 | 63.05B |
| November 02, 2026 | 64.24B |
| October 30, 2026 | 60.85B |
| October 29, 2026 | 61.88B |
| October 28, 2026 | 61.38B |
| October 27, 2026 | 65.19B |
| October 26, 2026 | 65.94B |
| October 23, 2026 | 66.10B |
| October 22, 2026 | 66.56B |
| October 21, 2026 | 64.39B |
| October 20, 2026 | 65.94B |
| October 19, 2026 | 65.17B |
| October 16, 2026 | 64.22B |
| October 15, 2026 | 63.86B |
| October 14, 2026 | 62.21B |
| October 13, 2026 | 62.66B |
| October 12, 2026 | 63.42B |
| October 09, 2026 | 61.82B |
| Date | Value |
|---|---|
| October 08, 2026 | 60.82B |
| October 07, 2026 | 60.15B |
| October 06, 2026 | 61.04B |
| October 05, 2026 | 61.34B |
| October 02, 2026 | 61.63B |
| October 01, 2026 | 62.54B |
| September 30, 2026 | 63.15B |
| September 29, 2026 | 63.48B |
| September 28, 2026 | 63.81B |
| September 25, 2026 | 63.54B |
| September 24, 2026 | 64.64B |
| September 23, 2026 | 64.55B |
| September 22, 2026 | 64.99B |
| September 21, 2026 | 63.25B |
| September 18, 2026 | 62.70B |
| September 17, 2026 | 63.00B |
| September 16, 2026 | 63.52B |
| September 15, 2026 | 63.47B |
| September 14, 2026 | 65.17B |
| September 11, 2026 | 62.18B |
| September 10, 2026 | 62.35B |
| September 09, 2026 | 65.04B |
| September 08, 2026 | 65.07B |
| September 04, 2026 | 69.15B |
| September 03, 2026 | 67.92B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 185.75B |
| Becton, Dickinson & Co. | 58.76B |
| Stryker Corp. | 118.93B |
| Insulet Corp. | 10.36B |
| The Cooper Cos., Inc. | 11.82B |
Market Cap Related Metrics
| PE Ratio | 18.71 |
| PS Ratio | 3.104 |
| PEG Ratio | 0.7103 |
| Price to Book Value | 2.500 |
| Price to Free Cash Flow | 19.63 |
| Price | 44.20 |
| Earnings Yield | 5.34% |
| PEGY Ratio | 0.7103 |
| Operating PE Ratio | 14.47 |
| Normalized PE Ratio | 17.33 |